Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.390
-0.070 (-1.57%)
Dec 20, 2024, 4:00 PM EST - Market closed
Radiopharm Theranostics Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '24 Dec 20, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Market Capitalization | 33 | 12 | 24 | 26 | - |
| Market Cap Growth | -50.78% | -50.78% | -10.18% | - | - |
| Enterprise Value | 21 | 10 | 8 | 4 | - |
| PS Ratio | 8.93 | 8.93 | 5.74 | - | - |
| PB Ratio | 0.64 | 0.64 | 0.78 | 0.61 | - |
| P/TBV Ratio | - | - | - | 5.56 | - |
| EV/Sales Ratio | 15.70 | 8.02 | 2.04 | - | - |
| Debt / Equity Ratio | - | - | - | - | -0.47 |
| Asset Turnover | 0.03 | 0.03 | 0.08 | - | - |
| Quick Ratio | 1.11 | 1.11 | 1.22 | 3.43 | 0.21 |
| Current Ratio | 1.30 | 1.30 | 1.23 | 3.46 | 0.21 |
| Return on Equity (ROE) | -131.49% | -131.49% | -63.77% | -96.82% | - |
| Return on Assets (ROA) | -30.04% | -30.04% | -22.57% | -29.86% | - |
| Return on Capital (ROIC) | -60.55% | -60.55% | -32.93% | -39.60% | - |
| Earnings Yield | -98.10% | -274.09% | -97.15% | -79.39% | - |
| FCF Yield | -44.05% | -131.34% | -65.25% | -25.86% | - |
| Buyback Yield / Dilution | -26.36% | -26.36% | -68.74% | - | - |
| Total Shareholder Return | -26.36% | -26.36% | -68.74% | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.